TrialBMC cancer2020
Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer.
Markus Hecht et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled ittrialcites it